CĂRȚI ÎN ENGLEZĂ ÎN LEGĂTURĂ CU «GLUCURONIDASE»
Descoperă întrebuințarea
glucuronidase în următoarea selecție bibliografică. Cărți în legătură cu
glucuronidase și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Engleză.
1
Spontaneous Animal Models of Human Disease
However, Beaudet et al., have described a patient with glucuronidase deficiency
who had normal stature and intelligence. Other traits, typical of this disease
include granular inclusions in leukocytes and accumulation of dermatan sulfate
and ...
Edwin J. Andrews, Billy C. Ward, Norman H. Altman, 1980
2
Prodrugs: challenges and rewards. P. 1
-Glucuronidase-activated Prodrugs The potential of -glucuronidase as a target
enzyme for activation of prodrugs in selective chemotherapy has been
established for a long time (Sperker et al., 1997). Already in 1966 a correlation
was found ...
Valentino J. Stella, 2007
3
Phase II Conjugation Enzymes and Transport Systems
[15] Glucuronidase Deconjugation in Inflammation By KAYOKO SHIMOI and
TSUTOMU NAKAYAMA Abstract This chapter focuses on deglucuronidation by /3
-glucuronidase in inflammation, We investigated whether glucuronides were ...
Helmut Sies, Lester Packer, 2005
4
Oral Colon-Specific Drug Delivery
Mammalian ft-D-Glucuronidase Activity p-o-Glucuronidase activity is found
distributed widely throughout the human body, including the GI tract.39 This
enzyme is found in the GI tract of infants and children, as well as several rodents,
during ...
5
Springer Handbook of Enzymes:
[3] Kim, D.-H.; Jang, H.-S.; Lee, S.-W.: Bacteroides J-37, a human intestinal
bacterium, produces a-glucuronidase. Biol. Pharm. Bull., 20, 834-837 (1997) [4]
Bronnenmeier, K.; Meissner, H.; Stocker, S.; Staudenbauer, W.L.: a-D-Glu-
curonidases ...
Dietmar Schomburg, Ida Schomburg, A. Chang, 2003
In fact, the measurement of B -glucuronidase and 8 - galactosidase has proved a
useful (and quantitative) method for detecting chemically induced peripheral
neuropathy (6,33). When applied to rats dosed orally for 7 days with 400 mg/kg
per ...
Kenneth Blum, L. Manzo, 1985
7
Genetic Effects on Aging
TOMINO, S., PAIGEN, K., TULSIANI, D. R. P., and TOUSTER, O. (1975)
Purification and chemical properties of mouse liver lysosomal (L-form) (p-
glucuronidase. J. Biol. Chem. 250: 8503-8509. DORFMAN, A., and MATALON, R.
(1976) The ...
8
Gallstones: Pathogenesis and Treatment
p-glucuronidase( + ) [}-glucuronidase( - ) * * * I ii. i- 0. 10 0.05 200 400 "0 time (
hours) 50 100 150 200 time (hours) Figure 4 Effect of p-glucuronidase on
cholesterol crystallization. The addition of p-glucuroni- dase showed no
significant ...
G. Adler, H.E. Blum, M. Fuchs, 2004
9
GUS Protocols: Using the GUS Gene as a Reporter of Gene ...
Low cost is another advantage of this assay. GUS Protocols provides instructions and essential background information that will enable researchers to effectively use the GUS gene as a reporter of the expression of introduced genes.
10
Genetic Disorders and the Fetus: Diagnosis, Prevention and ...
Isolation and expression in Escherichia coil of a cDNA clone encoding human
beta-glucuronidase. Gene 1985;34:105. 119. Oshima A, Kyle JW, Miller RD, et al.
Cloning, sequencing, and expression of cDNA for human beta-glucuro-nidase.
Aubrey Milunsky, Jeff Milunsky, 2011
ȘTIRI NOI CARE INCLUD TERMENUL «GLUCURONIDASE»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
glucuronidase în contextul următoarelor știri.
Rhizobium–legume symbiosis in the absence of Nod factors: two …
(1995). β-Glucuronidase (GUS) transposons for ecological and genetic studies of rhizobia and other Gram-negative bacteria. Microbiology 141: ... «Nature.com, Iul 15»
Stock Insights on Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)
The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. «Street Report, Iul 15»
Trending Stocks: PTC Therapeutics, Inc. (NASDAQ:PTCT …
... announced it has completed patient enrollment in the pivotal Phase 3 study of recombinant human beta-glucuronidase (rhGUS, UX003), ... «Stock Transcript, Iun 15»
Ultragenyx Announces Completion of Enrollment in Phase 3 Study …
MPS 7 is caused by the deficiency of beta-glucuronidase, an enzyme required for the breakdown of the glycosaminoglycans (GAGs) dermatan ... «Nasdaq, Iun 15»
OCLS Gets A Facelift, NBIX Halts Trials, CBYL For The Long Haul …
... Inc. (RARE) has completed patient enrollment in the pivotal phase III study of recombinant human beta-glucuronidase (rhGUS, UX003). «RTT News, Iun 15»
Stock Report on Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)
The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. «Street Report, Iun 15»
Vulcanisation accelerator biomonitoring: Urinary levels of 2 …
Enzymatic hydrolysis using β-glucuronidase/sulfatase was the best, releasing four times as much MBT from the conjugates as acid hydrolysis at ... «separationsNOW.com, Mai 15»
Drug metabolism: manipulating the microbiome
Meanwhile, around half of the microbes that inhabit the human gut produce an enzyme called beta-glucuronidase, which enables them to ... «The Pharmaceutical Journal, Mar 15»
Tissue-specific patterns of gene expression in the epithelium and …
Human β-glucuronidase (GUSB) was used as the normalization control based on its consistent expression across all samples in the microarray ... «BMC Blogs Network, Mar 15»
Ultragenyx Announces Positive 36-Week Data From Phase 1/2 …
MPS 7 is caused by the deficiency of beta-glucuronidase, an enzyme required for the breakdown of the glycosaminoglycans (GAGs) dermatan ... «GlobeNewswire, Feb 15»
